Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Goel

Showing results (1-10 of 440) with videos related to

Pageof 44
Sort By:
Digestive Diseases and Sciences|November 18, 2010
Somatostatin methylation as a biomarker for gastric cancer: ready for "prime time" or for further validation?Ajay Goel
Future Oncology (London, England)|November 24, 2017
Utilizing biomarkers in colorectal cancer: an interview with Ajay GoelAjay Goel
Gastroenterology|August 28, 2015
MicroRNAs as Therapeutic Targets in Colitis and Colitis-Associated Cancer: Tiny Players With a Giant ImpactAjay Goel
Epigenomics|January 27, 2022
The era of biomarkers and precision medicine in colorectal cancer: an interview with Ajay GoelAjay Goel
Future Oncology (London, England)|March 13, 2010
DNA methylation-based fecal biomarkers for the noninvasive screening of GI cancersAjay Goel
British Journal of Cancer|November 11, 2017
IGF-1R: SUMO-ing its weight in chemoresistant colorectal cancerAjay Goel
Digestive Diseases and Sciences|December 21, 2011
Colorectal cancer: sailing with a T-cell EMASTAjay Goel
Current Genomics|October 4, 2011
Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic reviewNaoshi Nishida, Ajay Goel
Molecular Cancer|November 19, 2024
Stool and blood biomarkers for colorectal cancer management: an update on screening and disease monitoringAlessandro Mannucci, Ajay Goel
European Journal of Cancer (Oxford, England : 1990)|July 12, 2022
Response to letter entitled re: A transcriptomic signature that predicts cancer recurrence after hepatectomy in patients with colorectal liver metastases: Add some analytical strategies would be betterYuma Wada, Ajay Goel
Pageof 44

Showing results (1-10 of 440) with videos related to

Sort By:
Pageof 44
Digestive Diseases and Sciences|November 18, 2010
Somatostatin methylation as a biomarker for gastric cancer: ready for "prime time" or for further validation?Ajay Goel
Future Oncology (London, England)|November 24, 2017
Utilizing biomarkers in colorectal cancer: an interview with Ajay GoelAjay Goel
Gastroenterology|August 28, 2015
MicroRNAs as Therapeutic Targets in Colitis and Colitis-Associated Cancer: Tiny Players With a Giant ImpactAjay Goel
Epigenomics|January 27, 2022
The era of biomarkers and precision medicine in colorectal cancer: an interview with Ajay GoelAjay Goel
Future Oncology (London, England)|March 13, 2010
DNA methylation-based fecal biomarkers for the noninvasive screening of GI cancersAjay Goel
British Journal of Cancer|November 11, 2017
IGF-1R: SUMO-ing its weight in chemoresistant colorectal cancerAjay Goel
Digestive Diseases and Sciences|December 21, 2011
Colorectal cancer: sailing with a T-cell EMASTAjay Goel
Current Genomics|October 4, 2011
Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic reviewNaoshi Nishida, Ajay Goel
Molecular Cancer|November 19, 2024
Stool and blood biomarkers for colorectal cancer management: an update on screening and disease monitoringAlessandro Mannucci, Ajay Goel
European Journal of Cancer (Oxford, England : 1990)|July 12, 2022
Response to letter entitled re: A transcriptomic signature that predicts cancer recurrence after hepatectomy in patients with colorectal liver metastases: Add some analytical strategies would be betterYuma Wada, Ajay Goel
Pageof 44